Imatinib 400 mg Tablets

Get a Price/Quote

MOQ : 100 Packs

Imatinib 400 mg Tablets Specification

Salt Composition
Imatinib Mesylate 400 mg

Dosage Form
Tablet

Indication
Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST), Acute Lymphoblastic Leukemia (ALL) (Philadelphia chromosome positive)

Feature
Oral solid dosage, film-coated, once daily dosing

Ingredients
Imatinib Mesylate, Excipients (Lactose, Cellulose, Magnesium Stearate, etc.)

Application
Anticancer agent for the treatment of certain blood cancers and gastrointestinal tumors

Physical Color/Texture
Light yellow to brownish-orange, film-coated tablet

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 - 36 months (as per manufacturer)

Regulatory Approvals
WHO-GMP/USFDA/EU-GMP compliant (depending on manufacturer)

Packaging
Blister pack of 10 or 30 tablets per box

Administration Route
Oral

ATC Code
L01XE01

Shape
Oval, biconvex tablet

Molecular Formula
C29H31N7OCH4SO3

Prescription Status
Prescription Only Medicine

Patient Group
Adults & Pediatric (as per clinical indication)

Strength
400 mg per tablet

Imatinib 400 mg Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Imatinib 400 mg Tablets

Imatinib 400 mg Tablets are an exceptional oral anticancer therapy, available in a rarefied supply-limited stock invites prompt purchase for those in need. Each biconvex, light yellow to brownish-orange tablet, praiseworthy for its efficacy, contains inestimable potency against certain blood cancers and gastrointestinal tumors. Supplied in secure blister packs of 10 or 30, this prescription-only medicine is WHO-GMP/USFDA/EU-GMP compliant, ensuring global regulatory trust. Buy Imatinib 400 mg Tablets from verified suppliers or traders in India to benefit from its proven strength in trusted hands.

Comprehensive Indication and Site of Application

Imatinib 400 mg Tablets are administered orally, allowing for simple and effective treatment at home or in clinical settings. Suitable for both adults and pediatric patients, their application surface is internal-targeting blood and gastrointestinal tissues as indicated. With its usage as a once-daily dose, these tablets support consistent, ongoing cancer therapy, optimizing patient adherence and outcomes.

Certified Quality and Global Export Efficiency

Holding prestigious WHO-GMP, USFDA, or EU-GMP certifications, Imatinib 400 mg Tablets are recognized for their premium manufacturing standards. Main export markets include Asia, Africa, Eastern Europe, Latin America, and the Middle East, facilitated through trusted Indian FOB ports. Competitive outlay and quick dispatch assures buyers of efficiency, reliability, and exceptional value in every transaction, elevating international pharmaceutical supply.

FAQ's of Imatinib 400 mg Tablets:

Q: How should Imatinib 400 mg Tablets be administered?

A: Imatinib 400 mg Tablets are taken orally with water, once daily, as prescribed by your healthcare provider. Follow the instructions on usage carefully for best results.

Q: What conditions are treated with Imatinib 400 mg Tablets?

A: Imatinib 400 mg is indicated for the treatment of Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST), and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (ALL).

Q: When is it necessary to purchase Imatinib 400 mg Tablets?

A: Imatinib 400 mg Tablets should be purchased after receiving a prescription from a qualified healthcare professional, based on a confirmed diagnosis and clinical recommendation for indicated cancers.

Q: Where are Imatinib 400 mg Tablets sourced from?

A: These tablets are supplied from India by authorized suppliers and traders, with compliance to international standards such as WHO-GMP, USFDA, or EU-GMP.

Q: What is the process for proper storage of Imatinib 400 mg Tablets?

A: Store the tablets below 30C, away from moisture and light, to maintain efficacy throughout the 24-36 month shelf life.

Q: What are the main benefits of choosing this anticancer agent?

A: Imatinib 400 mg Tablets offer proven, convenient, once-daily dosing with high regulatory assurance, making them a praiseworthy choice for eligible cancer patients.

Tell us about your requirement